September 14, 2026
Mint it
Now that the FDA has approved the Mint patch pump from Beta Bionics the race is on to battle Insulet. Tandem has filed with the FDA for its Tobi platform as has MiniMed with their Fit platform. So it won’t be long now before we have multiple patch pump platforms besides the Omnipod. This as they say is when the fun begins.
Let’s take a look at the current state of the patch pump segment which is pretty easy as Insulet basically owns it. Yes there are some minor players overseas such as ViCentra, who will likely land . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
